Potassium Acetate



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Parenteral Nutrition 31.8%
Drug Use For Unknown Indication 17.9%
Product Used For Unknown Indication 9.9%
Hypertension 8.6%
Total Parenteral Nutrition 6.0%
Atrial Fibrillation 5.3%
Intentional Overdose 2.6%
Pain 2.6%
Premedication 2.6%
Blood Cholesterol Increased 2.0%
Blood Potassium Decreased 1.3%
Burning Sensation 1.3%
Diabetes Mellitus 1.3%
Diabetes Mellitus Non-insulin-dependent 1.3%
Prophylaxis 1.3%
Sleep Disorder 1.3%
Anticoagulant Therapy 0.7%
Anxiety 0.7%
Breakthrough Pain 0.7%
Chronic Lymphocytic Leukaemia 0.7%
Product Compounding Quality Issue 8.0%
Ultrasound Abdomen Abnormal 8.0%
Upper Gastrointestinal Haemorrhage 8.0%
Ventricular Fibrillation 8.0%
Vomiting 8.0%
Depression 4.0%
Dizziness 4.0%
Drug Ineffective 4.0%
Hypotension 4.0%
Incorrect Dose Administered 4.0%
Intentional Overdose 4.0%
Multiple Drug Overdose 4.0%
Nausea 4.0%
Overdose 4.0%
Product Colour Issue 4.0%
Pyrexia 4.0%
Suicide Attempt 4.0%
Unevaluable Event 4.0%
Ventricular Tachycardia 4.0%
Weight Decreased 4.0%
Concomitant
Product Used For Unknown Indication 29.1%
Drug Use For Unknown Indication 15.7%
Hypertension 8.5%
Pain 4.8%
Diabetes Mellitus 3.6%
Multiple Myeloma 3.6%
Rheumatoid Arthritis 3.4%
Depression 3.3%
Gastrooesophageal Reflux Disease 3.0%
Asthma 3.0%
Blood Cholesterol Increased 2.8%
Diabetes Mellitus Non-insulin-dependent 2.6%
Osteoporosis 2.6%
Anxiety 2.3%
Atrial Fibrillation 2.3%
Chronic Obstructive Pulmonary Disease 2.2%
Supplementation Therapy 2.2%
Cardiac Disorder 1.8%
Prophylaxis 1.8%
Mineral Supplementation 1.5%
Weight Decreased 10.9%
Weight Increased 9.7%
Vomiting 7.6%
Death 5.7%
Drug Ineffective 5.7%
White Blood Cell Count Decreased 5.1%
Tremor 4.5%
Vision Blurred 4.5%
Visual Acuity Reduced 4.5%
Dyspnoea 4.2%
Myocardial Infarction 4.2%
Nausea 4.2%
Pain In Extremity 4.2%
Syncope 4.2%
Pharmaceutical Product Complaint 3.9%
Pneumonia 3.6%
Somnolence 3.6%
Rash 3.3%
Renal Failure Acute 3.0%
Urinary Tract Infection 3.0%
Interacting
Product Used For Unknown Indication 100.0%
Drug Interaction 50.0%
Hyperkalaemia 50.0%